The US Food and Drug Administration (FDA) has granted marketing authorisation to Cepheid’s Xpert HCV test and GeneXpert Xpress System.
This marks the first point-of-care hepatitis C RNA test that can be used in various healthcare settings, including substance use disorder treatment facilities,…
[ad_2]
Source link
